Otsuka Pharmaceutical Co., Ltd (TYO: 4578), abbreviated OPC, is a pharmaceutical company ... Otsuka's subsidiary Otsuka America will pay $100 million upfront for Neurovance, plus up-to $150 million in development and approval milestones ...
Otsuka in the U.S. From a family business to a global pharmaceutical business. Research and development of new pharmaceutical products and Digital Medicine. Fulfil your ... Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical, Inc. (OAPI) brings new medicines to market. OAPI commercializes Otsuka-developed and in-licensed products for use in ...
Otsuka in the U.S. has two companies that carry out research, clinical development and commercialization of ... Otsuka America Pharmaceutical, Inc. ( OAPI).
OTSUKA IN THE U.S. ... Otsuka America Pharmaceutical, Inc. 2440 Research Blvd, Rockville, ... Otsuka Pharmaceutical Development & Commercialization, Inc .
Otsuka in the U.S. offers a wide variety of careers in pharma. ... have already shown a level of excellence in what they do and now are looking for a new and exciting challenge in pharmaceutical sales. ... Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc., (OAPI) commercializes Otsuka-discovered and in-licensed products in the United States; its Canadian subsidiary, Otsuka ...
Corporate Headquarters/General Inquiries. Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA (301) 990-0030 phone; (800) 562-3974 toll free
Otsuka Group of Companies in the U.S.. Otsuka America Pharmaceutical, Inc. Otsuka Pharmaceutical Development & Commercialization, Inc. NEUROSCIENCE.